Praxsyn Corp (PXYN)

[Drugdoctor]

Wow, I was right on with that post, thanks for posting... re
"So that leaves us now with a NET PROFITABLE company as reported in the third quarter, with the prospects for much larger revenues and NET PROFITS in the fourth quarter, and then huge growth, and I am not hyping, HUGE GROWTH in 2015 in both Revenues and NET PROFITS."

And keep reading... because it gets better and better...

Gross Revenue - $27,600,000

Net Revenue - $17,600,000

Gross profit- $15,623,702

NET PROFITS before taxes - $5,500,000

NET PROFITS after taxes - $3,182,000

BASIC NET INCOME per SHARE - $0.01

Cash and cash equivalents, end of period - $4,839,476

Accounts receivable, net of current portion- $11,510,012

Total assets $26,004,489

Gross billings receivables sold $0.00 (no factoring)

Interest Expense

Interest expense for the second quarter of 2015 was $134,324 which predominantly resulted from interest on notes payable – no factoring was done in this period. For the comparable period of 2014, interest expense was $9,558,629 and consisted of factoring-related interest of $9,188,446 and other interest of $370,183.